Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors

Area of Science:

• Cancer Biology
• Cellular Mechanisms
• Molecular Oncology

Background:

• Tumors acquire invasive and dissemination abilities through specific protein stabilization.
• The role of protein degradation failure in cancer metastasis remains unclear.
• Chaperone-mediated autophagy (CMA) is a key protein degradation pathway.

Purpose of the Study:

• To investigate the impact of LAMP-2A deficiency on cancer aggressiveness and metastasis.
• To elucidate the mechanistic link between CMA, TGFβ signaling, and epithelial-mesenchymal transition (EMT).
• To determine the clinical relevance of LAMP-2A expression in metastatic cancer.

Main Methods:

• Generated human cancer cell-specific knockout (KO) of LAMP-2A.
• Assessed tumor cell dissemination, invasion, and metastasis in vivo.
• Analyzed LAMP-2A expression in clinical primary and metastatic tumor samples.
• Investigated the interplay between CMA, TGFβ signaling, and EMT-related proteins (e.g., TGFβR2).

Main Results:

• LAMP-2A KO promoted mesenchymal tumor aggressiveness, leading to widespread dissemination and metastasis.
• Metastatic lesions exhibited suppressed LAMP-2A expression compared to primary tumors.
• CMA deficiency exacerbated TGFβ signaling, while TGFβ inhibition repressed tumor growth.
• CMA degrades EMT-driving proteins like TGFβR2.

Conclusions:

• CMA, via LAMP-2A, functions as a tumor suppressor by negatively regulating TGFβ-driven EMT.
• Deficiency in CMA contributes to cancer cell invasiveness and metastasis.
• LAMP-2A expression levels correlate with metastatic potential in cancer patients.